{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:30:50Z","timestamp":1753893050830,"version":"3.41.2"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Res. Metr. Anal."],"abstract":"<jats:p>Charities investing on rare disease research greatly contribute to generate ground-breaking knowledge with the clear goal of finding a cure for their condition of interest. Although the amount of their investments may be relatively small compared to major funders, the advocacy groups' clear mission promotes innovative research and aggregates highly motivated and mission-oriented scientists. Here, we illustrate the case of Fondazione italiana di ricerca per la Sclerosi Laterale Amiotrofica (AriSLA), the main Italian funding agency entirely dedicated to amyotrophic lateral sclerosis research. An international benchmark analysis of publications derived from AriSLA-funded projects indicated that their mean relative citation ratio values (iCite dashboard, National Institutes of Health, U.S.) were very high, suggesting a strong influence on the referring international scientific community. An interesting trend of research toward translation based on the \u201ctriangle of biomedicine\u201d and paper citations (iCite) was also observed. Qualitative analysis on researchers' accomplishments was convergent with the bibliometric data, indicating a high level of performance of several working groups, lines of research that speak of progression toward clinical translation, and one study that has progressed from the investigation of cellular mechanisms to a Phase 2 international clinical trial. The key elements of the success of the AriSLA investment lie in: (i) the clear definition of the objectives (research with potential impact on patients, no matter how far), (ii) a rigorous peer-review process entrusted to an international panel of experts, (iii) diversification of the portfolio with <jats:italic>ad hoc<\/jats:italic> selection criteria, which also contributed to bringing new experts and younger scientists to the field, and (iv) a close interaction of AriSLA stakeholders with scientists, who developed a strong sense of belonging. Periodic review of the portfolio of investments is a vital practice for funding agencies. Sharing information between funding agencies about their own policies and research assessment methods and outcomes help guide the international debate on funding strategies and research directions to be undertaken, particularly in the field of rare diseases, where synergy is a relevant enabling factor.<\/jats:p>","DOI":"10.3389\/frma.2023.1067981","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T12:20:14Z","timestamp":1691151614000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The positive impact on translational research of Fondazione italiana di ricerca per la Sclerosi Laterale Amiotrofica (AriSLA), a non-profit foundation focused on amyotrophic lateral sclerosis. Convergence of ex-ante evaluation and ex-post outcomes when goals are set upfront"],"prefix":"10.3389","volume":"8","author":[{"given":"Stefania","family":"Guareschi","sequence":"first","affiliation":[]},{"given":"Maddalena","family":"Ravasi","sequence":"additional","affiliation":[]},{"given":"Danila","family":"Baldessari","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Pozzi","sequence":"additional","affiliation":[]},{"given":"Tiziana","family":"Zaffino","sequence":"additional","affiliation":[]},{"given":"Mario","family":"Melazzini","sequence":"additional","affiliation":[]},{"given":"Anna","family":"Ambrosini","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nn0803-783","volume":"6","year":"2003","journal-title":"Nat. Neurosci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/s41591-022-01934-9","article-title":"Ensuring a future for gene therapy for rare diseases","volume":"28","author":"Aiuti","year":"2022","journal-title":"Nat. Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/00140139.2012.661084","article-title":"A covert attention P300-based brain-computer interface","volume":"55","author":"Aloise","year":"2012","journal-title":"Geospell Ergon"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1101\/gad.194829.112","article-title":"Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection","volume":"26","author":"Avenda\u00f1o-V\u00e1zquez","year":"2012","journal-title":"Genes Dev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/emboj.2010.310","article-title":"TDP-43 regulates its mRNA levels through a negative feedback loop","volume":"30","author":"Ayala","year":"2011","journal-title":"EMBO J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2552","DOI":"10.1212\/WNL.0000000000010731","article-title":"Structural and functional brain connectome in motor neuron diseases: a multicenter MRI study","volume":"95","author":"Basaia","year":"2020","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13550-020-0607-5","article-title":"Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to (18F)-fluorodeoxyglucose PET\/CT images","volume":"10","author":"Bauckneht","year":"2020","journal-title":"EJNMMI Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fphys.2019.00897","article-title":"Metabolic reprogramming promotes myogenesis during aging","volume":"10","author":"Belli","year":"2019","journal-title":"Front. Physiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1074\/jbc.M111.288720","article-title":"Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln\/Asn-rich region","volume":"287","author":"Budini","year":"2012","journal-title":"J. Biol. Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1242.\/jcs.249706","article-title":"DROSHA is recruited to DNA damage sites by the MRN complex to promote non-homologous end joining","author":"Cabrini","year":"2021","journal-title":"J. Cell Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1242\/dmm.012955","article-title":"The San Francisco declaration on research assessment","volume":"6","author":"Cagan","year":"2013","journal-title":"Dis. Model Mech"},{"key":"B12","doi-asserted-by":"publisher","first-page":"034004","DOI":"10.1088\/1361-6579\/ab0d4b","article-title":"Information-domain method for the quantification of the complexity of the sympathetic baroreflex regulation in healthy subjects and amyotrophic lateral sclerosis patients","volume":"40","author":"Cairo","year":"2019","journal-title":"Physiol. Meas"},{"key":"B13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3109\/21678421.2013.803576","article-title":"Eye tracking communication devices in amyotrophic lateral sclerosis: impact on disability and quality of life","volume":"14","author":"Caligari","year":"2013","journal-title":"Amyotroph. Lat. Scler. Frontotemporal. Degener"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086720","article-title":"TDP-43 inclusion bodies formed in bacteria are structurally amorphous, non-amyloid and inherently toxic to neuroblastoma cells","author":"Capitini","year":"2014","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12192-017-0806-9","article-title":"The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases","volume":"23","author":"Cristofani","year":"2018","journal-title":"Cell Stress Chaperones"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/brain\/awab167","article-title":"The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial","volume":"144","author":"Dalla Bella","year":"2021","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100143","DOI":"10.1016.\/j.xnsj.2022.100143","article-title":"Evaluation of the national institutes of health\u2013supported relative citation ratio among American orthopedic spine surgery faculty: a new bibliometric measure of scientific influence","volume":"11","author":"Dijanic","year":"2022","journal-title":"N. Am. Spine Soc. J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1038\/ncomms14741","article-title":"FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons","volume":"8","author":"Errichelli","year":"2017","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.nicl.08002","article-title":"(2017). Multimodal structural MRI in the diagnosis of motor neuron diseases","volume":"16","author":"Ferraro","year":"2017","journal-title":"Neuroimage Clin"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1038\/s41598-018-20679-5","article-title":"Long non-coding and coding RNAs characterization in peripheral blood mononuclear cells and spinal cord from amyotrophic lateral sclerosis patients","volume":"8","author":"Gagliardi","year":"2018","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.molcel.07021","article-title":"(2016). A surveillance function of the HSPB8-BAG3-HSP70 chaperone complex ensures stress granule integrity and dynamism","volume":"63","author":"Ganassi","year":"2016","journal-title":"Mol Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.08022","article-title":"(2020). ALS genetics: gains, losses, and implications for future therapies","volume":"108","author":"Garam","year":"2020","journal-title":"Neuron"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41467-020-15644-8","article-title":"Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis","volume":"11","author":"Garofalo","year":"2020","journal-title":"Nat. Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16569","DOI":"10.1073\/pnas.0507655102","article-title":"An index to quantify an individual's scientific research output","volume":"102","author":"Hirsch","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000385","article-title":"The NIH open citation collection: a public access, broad coverage resource","author":"Hutchins","year":"","journal-title":"PLoS Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000416","article-title":"Predicting translational progress in biomedical research","author":"Hutchins","year":"","journal-title":"PLoS Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002541","article-title":"Relative Citation Ratio (RCR): a new metric that uses citation rates to measure influence at the article level","author":"Hutchins","year":"2016","journal-title":"PLoS Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nn.3688","article-title":"Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis","volume":"17","author":"Johnson","year":"2014","journal-title":"Nat Neurosci"},{"year":"2021","author":"Jong","key":"B29"},{"key":"B30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41582-020-00434-z","article-title":"Improving clinical trial outcomes in amyotrophic lateral sclerosis","volume":"17","author":"Kiernan","year":"2021","journal-title":"Nat. Rev. Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/jnnp-2014-308996","article-title":"Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study","volume":"86","author":"Lauria","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"101803","DOI":"10.1016\/j.pneurobio.2020.101803","article-title":"miR-129-5p: a key factor and therapeutic target in amyotrophic lateral sclerosis","volume":"190","author":"Loffreda","year":"2020","journal-title":"Prog. Neurobiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011119","article-title":"Rapamycin treatment for amyotrophic lateral sclerosis: protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)","author":"Mandrioli","year":"2018","journal-title":"Medicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1093\/brain\/awy152","article-title":"Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis","volume":"141","author":"Marini","year":"2018","journal-title":"Brain"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review.","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051740","article-title":"Hsp90-mediated regulation of DYRK3 couples stress granule disassembly and growth via mTORC1 signaling","author":"Mediani","year":"2021","journal-title":"EMBO Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1038\/s41598-017-02195-0","article-title":"Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice","volume":"7","author":"Mirra","year":"2017","journal-title":"Sci. Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.neuron.02027","article-title":"Genome-wide analyses identify KIF5A as a novel ALS gene","volume":"97","author":"Nicolas","year":"2018","journal-title":"Neuron"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1093\/brain\/awab333","article-title":"Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"144","author":"Pasetto","year":"2021","journal-title":"Brain"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1523\/JNEUROSCI.2462-16.2016","article-title":"Targeting extracellular cyclophilin a reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis","volume":"37","author":"Pasetto","year":"2017","journal-title":"J. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/08820538.2022.2088981","article-title":"The relative citation ratio: a brief primer on the national institutes of health-supported bibliometric","volume":"37","author":"Patel","year":"2022","journal-title":"Semin. Ophthalmol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s00415-015-7739-y","article-title":"TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations","volume":"262","author":"Pensato","year":"2015","journal-title":"J. Neurol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41556-019-0392-4","article-title":"Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors","volume":"21","author":"Pessina","year":"2019","journal-title":"Nat. Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/acn3.51660","article-title":"Impact of the national amyotrophic lateral sclerosis registry: analysis of registry-funded research","volume":"9","author":"Rechtman","year":"2022","journal-title":"Ann. Clin. Transl. Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.11.JNS192679","article-title":"Assessment of the NIH-supported relative citation ratio as a measure of research productivity among 1,687 academic neurological surgeons","volume":"31","author":"Reddy","year":"2020","journal-title":"J. Neurosurg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1474-4422(18)30406-X","article-title":"Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"18","author":"Riva","year":"2019","journal-title":"Lancet Neurol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"10105","DOI":"10.1038\/s41598-018-28366-1","article-title":"MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors","volume":"8","author":"Rizzuti","year":"2018","journal-title":"Sci. Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.07007","article-title":"(2014). Chronological requirements of TDP-43 function in synaptic organization and locomotive control","volume":"71","author":"Romano","year":"2014","journal-title":"Neurobiol. Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"104792","DOI":"10.1016\/j.nbd.2020.104792","article-title":"UsnRNP trafficking is regulated by stress granules and compromised by mutant ALS proteins","volume":"138","author":"Rossi","year":"2020","journal-title":"Neurobiol. Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1091\/mbc.E16-01-0037","article-title":"Article-level assessment of influence and translation in biomedical research","volume":"28","author":"Santangelo","year":"2017","journal-title":"Mol Biol Cell."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/bph.15738","article-title":"Repurposing of Trimetazidine for amyotrophic lateral sclerosis: a study in SOD1 G93A mice","volume":"179","author":"Scaricamazza","year":"2021","journal-title":"Br. J. Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"101087","DOI":"10.1016\/j.isci.2020.101087","article-title":"Skeletal-muscle metabolic reprogramming in ALS-SOD1 G93A mice predates disease onset and is a promising therapeutic target","volume":"23","author":"Scaricamazza","year":"2020","journal-title":"iScience"},{"key":"B55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12915-020-00767-7","article-title":"TDP-43 promotes the formation of neuromuscular synapses through the regulation of Disc-large expression in Drosophila skeletal muscles","volume":"18","author":"Strah","year":"2020","journal-title":"BMC Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154404","article-title":"Clustering scientific publications based on citation relations: a systematic comparison of different methods","author":"\u0160ubelj","year":"2016","journal-title":"PLoS ONE"},{"key":"B57","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5195\/jmla.2018.499","article-title":"The relative citation ratio: what is it and why should medical librarians care? J","volume":"106","author":"Surkis","year":"2018","journal-title":"Med. Libr. Assoc"},{"key":"B58","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1242\/dmm.029058","article-title":"Modelling amyotrophic lateral sclerosis: progress and possibilities","volume":"10","author":"Van Damme","year":"2017","journal-title":"Dis. Model Mech"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2021.1936557","article-title":"What is amyotrophic lateral sclerosis prevalence?","volume":"21","author":"Vasta","year":"2021","journal-title":"Amyotroph Lateral Scler. Frontotem. Degener."},{"key":"B60","doi-asserted-by":"publisher","first-page":"10780","DOI":"10.1096\/fj.201900474R","article-title":"Isolation and characterization of soluble human full-length TDP-43 associated with neurodegeneration","volume":"33","author":"Vivoli Vega","year":"2019","journal-title":"FASEB J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1479-5876-11-126","article-title":"Identifying translational science within the triangle of biomedicine","volume":"11","author":"Weber","year":"2013","journal-title":"J Transl Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature11280","article-title":"Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis","volume":"488","author":"Wu","year":"2012","journal-title":"Nature"}],"container-title":["Frontiers in Research Metrics and Analytics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frma.2023.1067981\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T12:20:19Z","timestamp":1691151619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frma.2023.1067981\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":62,"alternative-id":["10.3389\/frma.2023.1067981"],"URL":"https:\/\/doi.org\/10.3389\/frma.2023.1067981","relation":{},"ISSN":["2504-0537"],"issn-type":[{"type":"electronic","value":"2504-0537"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"article-number":"1067981"}}